Citrate: How to Get Started and What, When, and How to Monitor?

In most of the case, regional citrate anticoagulation is using diluted citrate around 1% depending on the types used in clinical practice. Diluted citrate is much more safer when compared to highly concentrated citrate around 4% or even more. In clinical practice, trisodium citrate is used in high c...

Descripción completa

Detalles Bibliográficos
Autores principales: Honore, Patrick M., De Bels, David, Preseau, Thierry, Redant, Sebastien, Spapen, Herbert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231307/
https://www.ncbi.nlm.nih.gov/pubmed/30425947
http://dx.doi.org/10.2478/jtim-2018-0026
_version_ 1783370195750879232
author Honore, Patrick M.
De Bels, David
Preseau, Thierry
Redant, Sebastien
Spapen, Herbert D.
author_facet Honore, Patrick M.
De Bels, David
Preseau, Thierry
Redant, Sebastien
Spapen, Herbert D.
author_sort Honore, Patrick M.
collection PubMed
description In most of the case, regional citrate anticoagulation is using diluted citrate around 1% depending on the types used in clinical practice. Diluted citrate is much more safer when compared to highly concentrated citrate around 4% or even more. In clinical practice, trisodium citrate is used in high concentration (around 30%) as a bactericidal agent with anticoagulant properties for locking deep venous catheters used in hemodialysis (HD; close to 25–30% of citrate). In this review article, buffer and anticoagulant potential of citrate are discussed during renal replacement therapy in critically ill patients with particular focus on the practical approach at the bedside.
format Online
Article
Text
id pubmed-6231307
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-62313072018-11-13 Citrate: How to Get Started and What, When, and How to Monitor? Honore, Patrick M. De Bels, David Preseau, Thierry Redant, Sebastien Spapen, Herbert D. J Transl Int Med Review Article In most of the case, regional citrate anticoagulation is using diluted citrate around 1% depending on the types used in clinical practice. Diluted citrate is much more safer when compared to highly concentrated citrate around 4% or even more. In clinical practice, trisodium citrate is used in high concentration (around 30%) as a bactericidal agent with anticoagulant properties for locking deep venous catheters used in hemodialysis (HD; close to 25–30% of citrate). In this review article, buffer and anticoagulant potential of citrate are discussed during renal replacement therapy in critically ill patients with particular focus on the practical approach at the bedside. Sciendo 2018-10-09 /pmc/articles/PMC6231307/ /pubmed/30425947 http://dx.doi.org/10.2478/jtim-2018-0026 Text en © 2018 Patrick M. Honore, David De Bels, Thierry Preseau, Sebastien Redant, Herbert D. Spapen, published by Sciendo http://creativecommons.org/licenses/by-nc-nd/3.0 This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
spellingShingle Review Article
Honore, Patrick M.
De Bels, David
Preseau, Thierry
Redant, Sebastien
Spapen, Herbert D.
Citrate: How to Get Started and What, When, and How to Monitor?
title Citrate: How to Get Started and What, When, and How to Monitor?
title_full Citrate: How to Get Started and What, When, and How to Monitor?
title_fullStr Citrate: How to Get Started and What, When, and How to Monitor?
title_full_unstemmed Citrate: How to Get Started and What, When, and How to Monitor?
title_short Citrate: How to Get Started and What, When, and How to Monitor?
title_sort citrate: how to get started and what, when, and how to monitor?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231307/
https://www.ncbi.nlm.nih.gov/pubmed/30425947
http://dx.doi.org/10.2478/jtim-2018-0026
work_keys_str_mv AT honorepatrickm citratehowtogetstartedandwhatwhenandhowtomonitor
AT debelsdavid citratehowtogetstartedandwhatwhenandhowtomonitor
AT preseauthierry citratehowtogetstartedandwhatwhenandhowtomonitor
AT redantsebastien citratehowtogetstartedandwhatwhenandhowtomonitor
AT spapenherbertd citratehowtogetstartedandwhatwhenandhowtomonitor

Ejemplares similares